Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anticancer vaccines.

Literature DB >> 17950885

Anticancer vaccines.

Abstract

With the tools of molecular biology and a greater understanding of mechanisms to harness the immune system, effective tumor immunotherapy is becoming a reality. This new class of therapeutics offers a more targeted, and therefore precise, approach to the treatment of cancer. The recent conditional licensure of a xenogeneic DNA vaccine for advanced canine malignant melanoma strongly suggests that immunotherapy can play an extremely important role alongside the classic cancer treatment triad components of surgery, radiation therapy, and chemotherapy.

Entities: Disease Species

Mesh：

Substances：
Cancer Vaccines

Year: 2007 PMID： 17950885 DOI： 10.1016/j.cvsm.2007.06.005

Source DB: PubMed Journal: Vet Clin North Am Small Anim Pract ISSN： 0195-5616 Impact factor: 2.093

Keyword Cloud
Cited

8 in total

1. Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.

Authors: Alessandra Gavazza; George Lubas; Arthur Fridman; Daniela Peruzzi; Joseph A Impellizeri; Laura Luberto; Emanuele Marra; Giuseppe Roscilli; Gennaro Ciliberto; Luigi Aurisicchio
Journal: Hum Gene Ther Date: 2013-08 Impact factor: 5.695

2. Oral malignant melanomas and other head and neck neoplasms in Danish dogs--data from the Danish Veterinary Cancer Registry.

Authors: Louise B Brønden; Thomas Eriksen; Annemarie T Kristensen
Journal: Acta Vet Scand Date: 2009-12-18 Impact factor: 1.695

3. Enhancement of antitumor immunity using a DNA-based replicon vaccine derived from Semliki Forest virus.

Authors: Liang Zhang; Yue Wang; Yi Xiao; Yu Wang; JinKai Dong; Kun Gao; Yan Gao; Xi Wang; Wei Zhang; Yuanji Xu; JinQi Yan; JiYun Yu
Journal: PLoS One Date: 2014-03-07 Impact factor: 3.240

4. Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines.

Authors: Megan N Breit; William C Kisseberth; Misty D Bear; Yosef Landesman; Trinayan Kashyap; Dilara McCauley; Michael G Kauffman; Sharon Shacham; Cheryl A London
Journal: BMC Vet Res Date: 2014-07-15 Impact factor: 2.741

5. In Vitro Evaluation of the Biological Responses of Canine Macrophages Challenged with PLGA Nanoparticles Containing Monophosphoryl Lipid A.

Authors: Delphine Guldner; Julianne K Hwang; Maria Clara D Cardieri; Meaghan Eren; Parissa Ziaei; M Grant Norton; Cleverson D Souza
Journal: PLoS One Date: 2016-11-11 Impact factor: 3.240

Anticancer vaccines.

1. Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.

2. Oral malignant melanomas and other head and neck neoplasms in Danish dogs--data from the Danish Veterinary Cancer Registry.

3. Enhancement of antitumor immunity using a DNA-based replicon vaccine derived from Semliki Forest virus.

4. Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines.

5. In Vitro Evaluation of the Biological Responses of Canine Macrophages Challenged with PLGA Nanoparticles Containing Monophosphoryl Lipid A.

6. Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.

Review 7. Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives.

8. A gene-based avian influenza vaccine in poultry.